How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

作者：M. J. Montoro, P. Acha, C. Haferlach, O. Chan, Víctor Navarro, Y. Kubota, Felicitas Schulz, Robert Briski, N. Al Ali, Blanca Xicoy, Laura Palomo, F. López-Cadenas, Francesc Bosch, M. Meggendorfer, Teresa González, L. N. Eder, A. Jerez, Yu-Hung Wang, Alessia Campagna, Beate Betz, V. Santini, Teresa Bernal, E. Such, Anne Sophie Platzbecker, Tariq Kewan, C. Gurnari, C. Zindel, Austin Kulasekararaj, M. Voso, M. Sekeres, Nicolas Díaz-Varela, A. Al-Kali, A. Polini, E. Diral, Mara Memoli, U. Platzbecker, D. Haase, A. Zeidan, M. Díez-Campelo, G. Garcia-Manero, D. Wiseman, M. D. Della Porta, U. Germing, J. Maciejewski, R. Komrokji, Francesc Solé, T. Haferlach, P. Fenaux, David Valcárcel · 发表于：Leukemia · 年份：2026 · DOI：10.1038/s41375-026-02939-w · 被引用次数：1 · 研究领域：Medicine